Why the study?
In-stent restenosis accounts for 10% of percutaneous coronary interventions in the USA, and paclitaxel-coated balloons represent an alternative to uncoated balloons for its treatment.
Does paclitaxel-coated balloon angioplasty reduce late lumen loss, restenosis, TLR, and MACE compared to uncoated balloons in patients with coronary in-stent restenosis?
Does paclitaxel-coated balloon angioplasty reduce late lumen loss, restenosis, TLR, and MACE compared to uncoated balloons in patients with coronary in-stent restenosis?
Paclitaxel-coated balloons significantly reduce late lumen loss, restenosis, target lesion revascularization, and MACE compared to uncoated balloons for the treatment of coronary in-stent restenosis.
Answers are grounded in this paper and cite their sources.
Supports paclitaxel-coated balloons for coronary in-stent restenosis; extends prior RCTs with meta-analytic confirmation.
BACKGROUND: Treatment of in-stent restenosis (ISR) accounts for 10% of percutaneous coronary interventions in the USA. Paclitaxel-coated balloons (PCBs) are an alternative to uncoated balloons (UCBs) for ISR. METHODS: We systematically searched PubMed, Scopus, and Cochrane Central for studies comparing PCB with UCB in treating ISR. Outcomes included late lumen loss, binary restenosis, target lesion revascularization (TLR), and major adverse cardiovascular events (MACE). RESULTS: Eight trials including 1410 patients [PCB in 865 (61%), follow-up 6 months to 10 years) were identified. Angiographic outcomes of late lumen loss [mean difference: -0.50 mm; 95% confidence interval (CI): -0.66 to -0.33; P < 0.01] and binary restenosis [relative risk (RR): 0.22; 95% CI: 0.13-0.40; P < 0.01] at 6-8 months were lower with PCB. TLR at 6 months (RR: 0.16; 95% CI: 0.06-0.40; P < 0.001) and 1 year (RR: 0.45; 95% CI: 0.31-0.66; P < 0.001), MACE at 6 months (RR: 0.25; 95% CI: 0.16-0.38; P < 0.001), MACE at 3-5 years (RR: 0.54; 95% CI: 0.37-0.80; P = 0.002), and TLR at 3-5 years (RR: 0.51; 95% CI: 0.29-0.90; P = 0.021) were lower with PCB. Meta-regression revealed that ISR lesions in the left anterior descending artery were associated with lower rates of binary restenosis while the opposite was observed for left circumflex lesions. CONCLUSION: Revascularization of coronary ISR with PCB is associated with reduced late lumen loss, binary restenosis, TLR, CCE, and MACE. PCB may be a preferred strategy for coronary ISR.
No takes yet. Share an insight, caveat, or question.
Krishna et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: